CHENGDU, China, Oct. 17, 2022 /PRNewswire/ The local government of Qingyang district in Chengdu, capital of Southwest China's Sichuan province, is striving to revitalize the district through urban renewal. Many old residential communities have had their appearance and functions overhauled. One community, known as Huanhua community, was built in 1998 and began renovations in 2021. "In addition to aging infrastructure, the old community mostly lacked convenient services, which we took into account during renovation," officials said. They have added facilities for the old and the young, and turned the road into a nature fitness trail. As a place that carries the essence of Chengdu's cultural roots, Qingyang district attaches great importance to cultural preservation during the urban renewal process. The district started the Xunxiang Road project in an effort to recreate an outdoor plum blossom corridor depicted in an ancient poem. "Fragrance lasts for 10 kilometer
XI'AN, China, Oct. 17, 2022 /PRNewswire/ LONGi, the world leading solar technology company headquartered in Xi'an, China, has partnered with Symbior Solar and Blue Solar to complete a 72kWp PV + 266kWh ESS + 60 kVA genset micro-grid system at Koh Jik island, Thailand. The Koh Jik ReCharge project is initiated and developed by Tanai Potisat, Founder of ReCharge Energy. Symbior and Blue Solar are the project investors. Apart from setting up the system, Koh Jik ReCharge also uplifts the local community to set up tariff structure and manage daily operation. The project showcases a new generation mini-grid for the electrification of Thai off-grid islands and a proof-of-concept for private-community social enterprise model. Koh Jik is a small fisherman island located in Chanthaburi province, and is one of the first islands in Thailand to build a renewable energy micro-grid, the island originally previously got gets its power mainly from diesel generation. The first micro-grid projec
MELBOURNE, Australia, Oct. 17, 2022 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved an investigational new drug (IND) application to commence a pivotal Phase III registration study of TLX591-CDx (Kit for the preparation of 68Ga-PSMA-11), for the imaging of prostate cancer using Positron Emission Tomography (PET) that will bridge to the marketing authorisation granted to Illuccix by the United States Food and Drug Administration (FDA). The IND application was submitted in partnership with Grand Pharmaceutical Group Limited (Grand Pharma), Telix's partner in the Greater China region. The bridging study is required to provide data obtained in a Chinese population to establish that the diagnostic efficacy of TLX591-CDx is equivalent in Chinese and Western populations. This study will enroll up to 110 patients with suspected recurrent
BEIJING, Oct. 17, 2022 /PRNewswire/ The 20th National Congress of the Communist Party of China (CPC) comes as China is striding forward on a new journey to build a modern socialist country in all respects. The CPC on Saturday unveiled the key agenda of its 20th National Congress, saying all preparations had been completed for the congress, which will open at 10 a.m. (local time) on Sunday in Beijing. The congress will envision the two stages toward building a great modern socialist country in all respects and set out strategic tasks and major measures for the next five years, Sun Yeli, spokesperson for the congress, told a news conference on Saturday afternoon. According to the two-step strategic plan, socialist modernization will be basically realized from 2020 to 2035. From 2035 to the mid-21st century, China will become a great modern socialist country, prosperous, strong, democratic, culturally advanced, harmonious and beautiful. "No matter how the world changes, China will
PITTSBURGH and SYDNEY, Oct. 17, 2022 /PRNewswire/ Net Health, a leading provider of specialty electronic health record (EHR) systems and advanced healthcare analytics, announced results from a first-of-its-kind study for a promising wound care treatment model. The findings showed Net Health Tissue Analytics, the company's AI-powered wound imaging and analysis software, helps clinicians provide more timely access to wound care services, enables patients to communicate faster with their specialists, and improves management of chronic wounds in remote populations. Net Health Tissue Analyticsis a best-in-class wound imaging and documentation solution that applies computer vision to images taken with traditional smartphones or tablets to automatically measure and document wound healing. The technology was recently granted Breakthrough Device status by the FDA for future development initiatives, becoming one of the few digital health solutions to achieve such recognition. It is one of